
Umer Raffat
Stock Analyst at Evercore ISI
(4.23)
# 1,515
Out of 5,119 analysts
157
Total ratings
51.7%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Reiterated: Buy | n/a | $166.89 | - | 17 | Oct 30, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | n/a | $28.53 | - | 2 | Oct 26, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | n/a | $99.30 | - | 4 | Sep 28, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Hold | n/a | $1,354.00 | - | 15 | Sep 23, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | n/a | $15.10 | - | 1 | Aug 25, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | n/a | $103.86 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | n/a | $63.89 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $248.35 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $12.97 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $25.74 | - | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $460.42 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.56 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.39 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.87 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.31 | +132.02% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $67.30 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.90 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.33 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.28 | n/a | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9298 | n/a | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.88 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.97 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $146.73 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $19.99 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.50 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $5.25 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.40 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.91 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $234.76 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $175.92 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.33 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $28.49 | n/a | 1 | Mar 9, 2018 |
Gilead Sciences
Oct 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $166.89
Upside: -
Parabilis Medicines
Oct 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.53
Upside: -
Kodiak Sciences
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $99.30
Upside: -
Eli Lilly and Company
Sep 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,354.00
Upside: -
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $15.10
Upside: -
Spyre Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $103.86
Upside: -
Vaxcyte
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.89
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $248.35
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $12.97
Upside: -
Elanco Animal Health
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.74
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $460.42
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.56
Upside: -
Apr 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.39
Upside: -
Apr 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.87
Upside: -
Mar 9, 2026
Reiterated: Buy
Price Target: $10
Current: $4.31
Upside: +132.02%
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $67.30
Upside: -
Nov 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $45.90
Upside: -
Nov 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.33
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.28
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.9298
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.88
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.97
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $146.73
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $19.99
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $29.50
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $5.25
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $23.40
Upside: n/a
Dec 9, 2021
Reiterated: Buy
Price Target: n/a
Current: $19.91
Upside: n/a
Jan 28, 2021
Reiterated: Buy
Price Target: n/a
Current: $234.76
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $175.92
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: n/a
Current: $2.33
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $28.49
Upside: n/a